On December 15th 2022, new recommendations for the treatment of patients with antibiotic-resistant tuberculosis were published by the World Health Organization (WHO) in Geneva. "This is a revolution," says Professor Christoph Lange, Medical Director at the Borstel Research Center and member of the WHO advisory panel. "Until now, patients with multidrug-resistant tuberculosis had to be treated for more than 18 months. Now the duration of therapy is reduced to just 6 months, exactly the same as for tuberculosis in which the bacteria do not exhibit antibiotic resistance. This quantum leap is made possible by combination therapy with new drugs. "And that could be just the beginning," Lange says. There are currently 17 new tuberculosis drugs in clinical development. As part of the European Commission-funded ERA4TB and UNITE4TB projects, physicians and scientists at the Borstel Research Center are involved in the clinical testing of these drugs. From summer 2023, the first patients will receive new drug combinations as part of these trials in African, Asian, European and South American study centers.
Prof. Dr. med. Dr. h.c. Christoph Lange Medical Director, Research Center Borstel, Leibniz Lung Center Professor of Respiratory Medicine & International Health, University of Lübeck Parkallee 35 D-23845 Borstel Germany
T +49 4537 188 3321/0 F +49 4537 188 6030 This email address is being protected from spambots. You need JavaScript enabled to view it.
Der Förderverein am Forschungszentrum Borstel verleiht den Preis für die beste Bachelorarbeit an Hannah Paulina Ketelsen
Details
16.12.2022
Um Nachwuchswissenschaftler*Innen zu fördern verleiht der Förderverein am Forschungszentrum Borstel jedes Jahr den Preis für die beste Master- oder Bachelorarbeit.
Dieses Mal geht der Preis rückwirkend für das Jahr 2021 an Frau Hannah Paulina Ketelsen, die ihre Bachelorarbeit am Nationalen Referenzzentrum für Mykobakterien unter der wissenschaftlichen Anleitung von Frau Dr. Doris Hillemann und Prof. Dr. Florian Maurer gemacht hat. Dabei hat sie neue diagnostische Verfahren getestet, um auf molekularer Ebene schnell Antibiotika-Resistenzen von Mykobakterien nachzuweisen, was besonders bei der richtigen Therapie von einer Erkrankung mit multiresistenten Keimen eine wichtige Rolle spielt.
Der Preis ist mit 500€ dotiert. Herzlichen Glückwunsch!
Das Forschungszentrum trauert um Arno Hamdorf
Details
08.12.2022
Arno Hamdorf aus Seth war von August 1980 bis Dezember 2022 in der Außenbetriebsgruppe des Technischen Gebäudemanagements am Forschungszentrum Borstel beschäftigt.
Wir kannten ihn als zurückhaltenden, freundlichen und loyalen Menschen, der immer bereit war, sich für die Belange des Zentrums einzusetzen.
Wir werden ihn als sehr schätzenswerten Mitarbeiter in Erinnerung halten. Unser aller Mitgefühl gilt seiner Familie.
Nation-wide survey: TB services in Ukraine still operating
Details
28.10.2022
What impact does the military invasion by the Russian Federation have on the TB services in Ukraine? Already before war, Ukraine had one of the highest TB incidences in the WHO European Region, and one of the highest rates of multidrug-resistant TB (MDR-TB) worldwide.
SIYAKHULA - Growing HIV/TB Research Knowledge for Growing Healthy Kids in Eswatini
Details
18.10.2022
In siSwati, the language of people of eSwatini (formerly named Swaziland), “Siyakhula” means “Together We Grow”. The health care system of the small Kingdom in the South of Africa faces many challenges: Infectious diseases rule everyday life in eSwatini. More than 1/4 of the population is infected with the Human Immunodeficiency Virus (HIV). In addition, the country has one of the highest rates of tuberculosis world-wide.
